Minjung Lee Selected Research

Phosphotransferases (Kinase)

8/2014	UNC2025, a potent and orally bioavailable MER/FLT3 dual inhibitor.
12/2013	Discovery of Mer specific tyrosine kinase inhibitors for the treatment and prevention of thrombosis.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Minjung Lee Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 03/2009
3	Carcinoma (Carcinomatosis) 05/2015 - 01/2014
3	Epstein-Barr Virus Infections 05/2015 - 01/2014
2	Ovarian Neoplasms (Ovarian Cancer) 01/2022 - 04/2018
2	Inflammation (Inflammations) 12/2019 - 05/2015
2	Infections 12/2019 - 07/2015
2	Tuberculosis (Tuberculoses) 03/2016 - 07/2015
1	Hypersensitivity (Allergy) 01/2022
1	Hematologic Diseases (Blood Diseases) 01/2022
1	Ovarian Epithelial Carcinoma 01/2022
1	Melanoma (Melanoma, Malignant) 01/2021
1	Acute Erythroblastic Leukemia (Erythroleukemia) 01/2021
1	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 01/2021
1	COVID-19 01/2021
1	Medulloblastoma 10/2020
1	Leukemia 01/2020
1	Hematologic Neoplasms (Hematological Malignancy) 12/2019
1	Colonic Neoplasms (Colon Cancer) 01/2019
1	Prostatic Neoplasms (Prostate Cancer) 12/2018
1	Chronic Renal Insufficiency 12/2018
1	Lymphoma (Lymphomas) 04/2018
1	Breast Neoplasms (Breast Cancer) 04/2018
1	Triple Negative Breast Neoplasms 04/2018
1	Disease Progression 12/2017
1	Pre-Eclampsia (Preeclampsia) 01/2017
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2014
1	Necrosis 01/2014
1	Thrombosis (Thrombus) 12/2013
1	Hemorrhage 12/2013
1	Latent Infection 10/2013
1	Herpesviridae Infections (Herpesvirus Infection) 10/2013
1	Fatigue 03/2012
1	Phototoxic Dermatitis (Phototoxicity) 12/2009
1	Carcinogenesis 03/2009

Drug/Important Bio-Agent (IBA)

4	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 01/2017
4	Antiviral Agents (Antivirals)IBA 01/2021 - 01/2014
2	ChromatinIBA 01/2020 - 05/2015
2	Anti-Bacterial Agents (Antibiotics)IBA 12/2019 - 03/2016
2	Phosphotransferases (Kinase)IBA 08/2014 - 12/2013
1	Carboplatin (JM8)FDA LinkGeneric 01/2022
1	Transcription Factors (Transcription Factor)IBA 01/2022
1	DNA Methyltransferase 3AIBA 01/2022
1	MethyltransferasesIBA 01/2021
1	hydrogen sulfite (bisulfite)IBA 01/2021
1	VaccinesIBA 01/2021
1	Messenger RNA (mRNA)IBA 01/2021
1	Immune Checkpoint InhibitorsIBA 01/2021
1	Azacitidine (5 Azacytidine)FDA Link 01/2021
1	Cell-Free Nucleic AcidsIBA 10/2020
1	Circulating Tumor DNAIBA 10/2020
1	AndrogensIBA 12/2018
1	SodiumIBA 12/2018
1	Small Interfering RNA (siRNA)IBA 04/2018
1	Histone MethyltransferasesIBA 04/2018
1	Deubiquitinating EnzymesIBA 04/2018
1	Purinergic P1 Receptors (Adenosine Receptor)IBA 01/2017
1	Adenosine DeaminaseIBA 01/2017
1	Adenosine (Adenocard)FDA LinkGeneric 01/2017
1	Adenosine Monophosphate (AMP)IBA 01/2017
1	AutoantibodiesIBA 01/2017
1	Indicators and Reagents (Reagents)IBA 07/2015
1	Ursolic AcidIBA 07/2015
1	AntioxidantsIBA 07/2015
1	Carboxylic AcidsIBA 07/2015
1	TriterpenesIBA 07/2015
1	isoliquiritigenin (GU 17)IBA 05/2015
1	Antineoplastic Agents (Antineoplastics)IBA 05/2015
1	Anti-Asthmatic Agents (Antiasthmatic Drugs)IBA 05/2015
1	Monoamine Oxidase Inhibitors (Monoamine Oxidase Inhibitor)IBA 05/2015
1	QuercetinIBA 05/2015
1	genipinIBA 02/2015
1	cordycepinIBA 01/2014
1	CollagenIBA 12/2013
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 12/2013
1	Tyrosine Kinase InhibitorsIBA 12/2013
1	NucleosidesIBA 10/2013
1	Ascorbic Acid (Vitamin C)FDA LinkGeneric 12/2009
1	Proteins (Proteins, Gene)FDA Link 03/2009
1	Proto-Oncogene Proteins c-etsIBA 03/2009

Therapy/Procedure

4	Therapeutics 01/2019 - 12/2013
1	Drug Therapy (Chemotherapy) 01/2019
1	Sodium-Restricted Diet (Diet, Sodium Restricted) 12/2018
1	Radiotherapy 12/2018
1	Enzyme Replacement Therapy 01/2017
1	Activities of Daily Living (ADL) 03/2012